Abpro CEO Ian Chan wants antibodies ‘future-proofed’ against variants

Abpro thinks that an early-stage candidate, an antibody called ABP 310, will effectively shut down Covid-19 linked to the fast-spreading omicron variant, even with the virus’ many structural mutations.
Click here to view original post